Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Melanoma (Skin): early-phase trial registry
7 of 54 indexed Melanoma (Skin) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #261 of 28,707 conditions by registered trial count.
54 US clinical trials · 7 currently recruiting · #261 of 28,707 conditions by registered trial count
Melanoma (Skin): 54 US clinical trials tracked, 7 recruiting.
Melanoma (Skin) is the subject of 54 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 10 of these trials.
Enrollment posture brief
Registry condition melanoma-skin
OPEN 7 | RECR 13% | LATE 1 | EARLY 49 | RANK #261 | SPON 10
Volume-matched condition peers
Nearest open-share peer: Myocardial Ischemia (13% recruiting · 31 trials)
Melanoma (Skin) lists 7 open slots (13% of 54 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Melanoma (Skin) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Melanoma (Skin) is recruiting below its size-band peers.
7 of 54 indexed trials (13%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Melanoma (Skin) research.
National Cancer Institute (NCI) accounts for 10 of 54 trials (18.5%). 33 distinct sponsors appear on at least one study for this condition label.
-
Most Melanoma (Skin) trials plan to enrol fewer than 100 people.
Median target enrolment is 35 among the 31 trials that report a genuine target (sentinel values excluded). 23 of those (74.2%) plan for fewer than 100 participants.
-
Melanoma (Skin) research is mostly interventional.
53 interventional and 1 observational studies make up this index (98.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
54 total, page 2 of 2
Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma
St. Luke's Medical Center
NCT00002535
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
University of Rochester
NCT00004016
Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
Memorial Sloan Kettering Cancer Center
NCT00005815
Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
National Cancer Institute (NCI)
NCT00091338
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 27 |
| Phase 2 | 22 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Melanoma (Skin) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Melanoma (Skin) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Melanoma (Skin) page
54 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Melanoma (Skin) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Melanoma (Skin) trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Melanoma (Skin) condition card totals 54 registered trials; most-linked intervention aldesleukin; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.